Virpax Pharmaceuticals Inc Financial Flexibility Index
Virpax Pharmaceuticals Inc financial flexibility index. Virpax Pharmaceuticals Inc (VRPX) has a Financial Flexibility Index of -1.16x as of December 2024. Free cash flow of $-2.87 Million (operating CF $-2.87 Million minus capex $0.00) represents -1% of total liabilities ($2.47 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Virpax Pharmaceuticals Inc (2018–2024)
Financial flexibility index of Virpax Pharmaceuticals Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Virpax Pharmaceuticals Inc across 7 annual periods. Explore cash flow to debt ratio of Virpax Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Virpax Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2024)
Virpax Pharmaceuticals Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Virpax Pharmaceuticals Inc. For the full cash flow conversion analysis, see Virpax Pharmaceuticals Inc (VRPX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.77x | $-16.71 Billion | $-16.71 Billion | $2.47 Billion | ▼ -428.5% |
| 2023 | -1.28x | $-9.85 Million | $-9.85 Million | $7.69 Million | ▲ +77.8% |
| 2022 | -5.77x | $-17.85 Million | $-17.85 Million | $3.09 Million | ▲ +17.2% |
| 2021 | -6.97x | $-14.54 Million | $-14.54 Million | $2.09 Million | ▼ -2254.8% |
| 2020 | -0.30x | $-1.38 Million | $-1.38 Million | $4.68 Million | ▲ +27.4% |
| 2019 | -0.41x | $-1.13 Million | $-1.13 Million | $2.78 Million | ▲ +71.6% |
| 2018 | -1.43x | $-1.80 Million | $-1.80 Million | $1.25 Million | — |